{"id":"https://openalex.org/W3134400165","doi":"https://doi.org/10.1042/cs20200331","title":"Mechanisms and clinical manifestations of cardiovascular toxicities associated with immune checkpoint inhibitors","display_name":"Mechanisms and clinical manifestations of cardiovascular toxicities associated with immune checkpoint inhibitors","publication_year":2021,"publication_date":"2021-03-01","ids":{"openalex":"https://openalex.org/W3134400165","doi":"https://doi.org/10.1042/cs20200331","mag":"3134400165","pmid":"https://pubmed.ncbi.nlm.nih.gov/33686402","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8647663"},"language":"en","primary_location":{"id":"doi:10.1042/cs20200331","doi":"https://doi.org/10.1042/cs20200331","is_oa":false,"landing_page_url":"https://doi.org/10.1042/cs20200331","pdf_url":null,"source":{"id":"https://openalex.org/S206649051","display_name":"Clinical Science","issn_l":"0143-5221","issn":["0143-5221","1470-8736"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311608","host_organization_name":"Portland Press","host_organization_lineage":["https://openalex.org/P4310311608","https://openalex.org/P4310311715"],"host_organization_lineage_names":["Portland Press","Biochemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Science","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8647663","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022136914","display_name":"Alan H. Baik","orcid":"https://orcid.org/0000-0001-8840-8825","observed_orcids":["https://orcid.org/0000-0001-8840-8825"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210110664","display_name":"University of California San Francisco Medical Center","ror":"https://ror.org/01t8svj65","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210110664"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alan H. Baik","raw_affiliation_strings":["UCSF Department of Medicine, Division of Cardiology, San Francisco, CA 94143, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCSF Department of Medicine, Division of Cardiology, San Francisco, CA 94143, U.S.A","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210110664"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088042471","display_name":"Katy K. Tsai","orcid":"https://orcid.org/0000-0002-7705-1813","observed_orcids":["https://orcid.org/0000-0002-7705-1813"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210110664","display_name":"University of California San Francisco Medical Center","ror":"https://ror.org/01t8svj65","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210110664"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katy K. Tsai","raw_affiliation_strings":["UCSF Department of Medicine, Division of Hematology/Oncology, San Francisco, CA 94143, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCSF Department of Medicine, Division of Hematology/Oncology, San Francisco, CA 94143, U.S.A","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210110664"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058893054","display_name":"David Yoonsuk Oh","orcid":"https://orcid.org/0000-0002-3310-0994","observed_orcids":["https://orcid.org/0000-0002-3310-0994"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210110664","display_name":"University of California San Francisco Medical Center","ror":"https://ror.org/01t8svj65","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210110664"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Y. Oh","raw_affiliation_strings":["UCSF Department of Medicine, Division of Hematology/Oncology, San Francisco, CA 94143, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCSF Department of Medicine, Division of Hematology/Oncology, San Francisco, CA 94143, U.S.A","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210110664"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111065710","display_name":"Mandar A. Aras","orcid":"https://orcid.org/0000-0002-7528-4971","observed_orcids":["https://orcid.org/0000-0002-7528-4971"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210110664","display_name":"University of California San Francisco Medical Center","ror":"https://ror.org/01t8svj65","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210110664"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Mandar A. Aras","raw_affiliation_strings":["UCSF Department of Medicine, Division of Cardiology, San Francisco, CA 94143, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCSF Department of Medicine, Division of Cardiology, San Francisco, CA 94143, U.S.A","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210110664"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5111065710"],"corresponding_institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210110664"],"apc_list":null,"apc_paid":null,"fwci":0.5747,"has_fulltext":false,"cited_by_count":42,"citation_normalized_percentile":{"value":0.55635492,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":100},"biblio":{"volume":"135","issue":"5","first_page":"703","last_page":"724"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11535","display_name":"Chemotherapy-induced cardiotoxicity and mitigation","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11638","display_name":"Cardiac tumors and thrombi","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.7720000147819519},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.9810000061988831},{"id":"https://openalex.org/keywords/myocarditis","display_name":"myocarditis","score":0.9010000228881836},{"id":"https://openalex.org/keywords/pericarditis","display_name":"pericarditis","score":0.8270000219345093},{"id":"https://openalex.org/keywords/vasculitis","display_name":"vasculitis","score":0.9179999828338623},{"id":"https://openalex.org/keywords/ctla-4","display_name":"CTLA-4","score":0.9049999713897705},{"id":"https://openalex.org/keywords/pd-1-pd-l1","display_name":"PD-1/PD-L1","score":0.8820000290870667},{"id":"https://openalex.org/keywords/immunotherapy-side-effects","display_name":"immunotherapy side effects","score":0.6290000081062317}],"concepts":[{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.7605700492858887},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5839572548866272},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5645901560783386},{"id":"https://openalex.org/C2780875844","wikidata":"https://www.wikidata.org/wiki/Q186235","display_name":"Myocarditis","level":2,"score":0.5566855669021606},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.5316990613937378},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5281912088394165},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.49881911277770996},{"id":"https://openalex.org/C21705690","wikidata":"https://www.wikidata.org/wiki/Q2907609","display_name":"CTLA-4","level":4,"score":0.4457830488681793},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.43821319937705994},{"id":"https://openalex.org/C2779341262","wikidata":"https://www.wikidata.org/wiki/Q182581","display_name":"Immunity","level":3,"score":0.4339357912540436},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.43354135751724243},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.4207797050476074},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.41722023487091064},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.4138430953025818},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.3598475456237793},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3588011860847473},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2420038878917694},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.2420012354850769},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.21609246730804443},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1776289939880371},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000074322","descriptor_name":"Antineoplastic Agents, Immunological","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000082082","descriptor_name":"Immune Checkpoint Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D009205","descriptor_name":"Myocarditis","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D066126","descriptor_name":"Cardiotoxicity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1042/cs20200331","doi":"https://doi.org/10.1042/cs20200331","is_oa":false,"landing_page_url":"https://doi.org/10.1042/cs20200331","pdf_url":null,"source":{"id":"https://openalex.org/S206649051","display_name":"Clinical Science","issn_l":"0143-5221","issn":["0143-5221","1470-8736"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311608","host_organization_name":"Portland Press","host_organization_lineage":["https://openalex.org/P4310311608","https://openalex.org/P4310311715"],"host_organization_lineage_names":["Portland Press","Biochemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Science","raw_type":"journal-article"},{"id":"pmid:33686402","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33686402","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical science (London, England : 1979)","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8647663","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8647663","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Clin Sci (Lond)","raw_type":"Text"},{"id":"pmh:oai:escholarship.org:ark:/13030/qt1sh8x88j","doi":null,"is_oa":false,"landing_page_url":"https://escholarship.org/uc/item/1sh8x88j","pdf_url":null,"source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Clinical Science, vol 135, iss 5","raw_type":"article"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:8647663","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8647663","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Clin Sci (Lond)","raw_type":"Text"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G8650473052","display_name":"Identification of circulating and tissue-specific autoimmune responses in checkpoint inhibitor-induced immune-related adverse events","funder_award_id":"K08AI139375","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G9000072859","display_name":"Molecular and Cellular Basis of Cardiovascular Disease","funder_award_id":"T32HL007731","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"}],"funders":[{"id":"https://openalex.org/F4320337338","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":106,"referenced_works":["https://openalex.org/W1534774246","https://openalex.org/W1574315642","https://openalex.org/W1893566975","https://openalex.org/W1963707867","https://openalex.org/W1972575408","https://openalex.org/W1978354618","https://openalex.org/W1983000449","https://openalex.org/W1986659781","https://openalex.org/W1986954791","https://openalex.org/W1987316799","https://openalex.org/W1992987036","https://openalex.org/W2010068120","https://openalex.org/W2015085911","https://openalex.org/W2063922831","https://openalex.org/W2071871218","https://openalex.org/W2076067786","https://openalex.org/W2098853737","https://openalex.org/W2101386197","https://openalex.org/W2104373525","https://openalex.org/W2106473563","https://openalex.org/W2114972737","https://openalex.org/W2117443086","https://openalex.org/W2122208957","https://openalex.org/W2130852062","https://openalex.org/W2135175382","https://openalex.org/W2137187071","https://openalex.org/W2140419562","https://openalex.org/W2140921081","https://openalex.org/W2143378678","https://openalex.org/W2195401421","https://openalex.org/W2301851804","https://openalex.org/W2395845086","https://openalex.org/W2404485673","https://openalex.org/W2406536327","https://openalex.org/W2427648338","https://openalex.org/W2510390828","https://openalex.org/W2525217971","https://openalex.org/W2547133566","https://openalex.org/W2549414845","https://openalex.org/W2560367415","https://openalex.org/W2566702711","https://openalex.org/W2580651357","https://openalex.org/W2581891606","https://openalex.org/W2597105572","https://openalex.org/W2613895045","https://openalex.org/W2622351417","https://openalex.org/W2637316398","https://openalex.org/W2737436316","https://openalex.org/W2744958889","https://openalex.org/W2766590818","https://openalex.org/W2767587838","https://openalex.org/W2767935837","https://openalex.org/W2769632314","https://openalex.org/W2771433910","https://openalex.org/W2786816161","https://openalex.org/W2789315292","https://openalex.org/W2791483720","https://openalex.org/W2793167197","https://openalex.org/W2793937680","https://openalex.org/W2794109650","https://openalex.org/W2795067517","https://openalex.org/W2795318100","https://openalex.org/W2797107996","https://openalex.org/W2809144995","https://openalex.org/W2883638671","https://openalex.org/W2886247697","https://openalex.org/W2891486030","https://openalex.org/W2896676995","https://openalex.org/W2899044337","https://openalex.org/W2901191795","https://openalex.org/W2901974641","https://openalex.org/W2908431216","https://openalex.org/W2911320085","https://openalex.org/W2918258736","https://openalex.org/W2929415048","https://openalex.org/W2945464379","https://openalex.org/W2949277199","https://openalex.org/W2950056455","https://openalex.org/W2955729565","https://openalex.org/W2966126559","https://openalex.org/W2968462573","https://openalex.org/W2969473108","https://openalex.org/W2980932212","https://openalex.org/W2989584137","https://openalex.org/W2994726901","https://openalex.org/W3002425056","https://openalex.org/W3003308809","https://openalex.org/W3007666278","https://openalex.org/W3010374810","https://openalex.org/W3021805222","https://openalex.org/W3025232850","https://openalex.org/W3031059687","https://openalex.org/W3031115858","https://openalex.org/W3084157711","https://openalex.org/W3088018189","https://openalex.org/W3089761109","https://openalex.org/W3104562917","https://openalex.org/W3105486497","https://openalex.org/W3108805504","https://openalex.org/W3110800814","https://openalex.org/W3112795121","https://openalex.org/W3112902030","https://openalex.org/W3122002269","https://openalex.org/W4211219019","https://openalex.org/W4233477747","https://openalex.org/W6713986937"],"related_works":["https://openalex.org/W2913202760","https://openalex.org/W4290189253","https://openalex.org/W4327949254","https://openalex.org/W3033064223","https://openalex.org/W7171616233","https://openalex.org/W4296462914","https://openalex.org/W4391536682","https://openalex.org/W4416528205","https://openalex.org/W4378176784","https://openalex.org/W4392236024"],"abstract_inverted_index":{"Immunotherapies":[0],"have":[1,28,33],"greatly":[2],"expanded":[3],"the":[4,10,14,103,112,140],"armamentarium":[5],"of":[6,40,51,87,115],"cancer-directed":[7],"therapies":[8],"in":[9,26,37,72],"past":[11],"decade,":[12],"allowing":[13],"immune":[15,78],"system":[16,79],"to":[17],"recognize":[18],"and":[19,32,67,127,132,144],"fight":[20],"cancer.":[21,41],"Immune":[22],"checkpoint":[23],"inhibitors":[24],"(ICIs),":[25],"particular,":[27],"revolutionized":[29],"cancer":[30],"treatment":[31],"demonstrated":[34],"survival":[35],"benefit":[36],"numerous":[38],"types":[39],"These":[42],"monoclonal":[43],"antibodies":[44],"increase":[45,77],"anti-cancer":[46],"immunity":[47],"by":[48],"blocking":[49],"down-regulators":[50],"adaptive":[52],"immunity,":[53],"including":[54],"cytotoxic":[55],"T":[56],"lymphocyte-associated":[57],"protein":[58,64],"4":[59],"(CTLA-4),":[60],"programmed":[61],"cell":[62],"death":[63],"1":[65],"(PD-1),":[66],"its":[68],"ligand":[69],"(PD-L1),":[70],"resulting":[71],"anti-tumor":[73],"activity.":[74],"As":[75],"ICIs":[76],"activation,":[80],"they":[81],"can":[82,98],"cause":[83],"a":[84],"wide":[85],"range":[86],"inflammatory":[88],"side":[89],"effects,":[90],"termed":[91],"immune-released":[92],"adverse":[93,136],"events.":[94],"Though":[95],"these":[96],"toxicities":[97,117],"affect":[99],"nearly":[100],"any":[101],"organ,":[102],"most":[104],"fatal":[105],"toxicity":[106],"is":[107],"myocarditis.":[108],"Here,":[109],"we":[110,124],"discuss":[111],"diverse":[113],"spectrum":[114],"cardiovascular":[116],"associated":[118],"with":[119],"ICI":[120],"use.":[121],"In":[122],"addition,":[123],"provide":[125],"insight":[126],"future":[128],"directions":[129],"on":[130],"mechanisms":[131],"treatments":[133],"for":[134],"immune-related":[135],"events":[137],"(irAEs)":[138],"involving":[139],"myocardium,":[141],"pericardium,":[142],"vasculature,":[143],"conduction":[145],"system.":[146]},"counts_by_year":[{"year":2026,"cited_by_count":9},{"year":2025,"cited_by_count":14},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":9},{"year":2021,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2021-03-15T00:00:00"}